Skip to content

Hensley Mark Earl

Reporting owner on Forms 3, 4 and 5, CIK 2065816.

Hensley Mark Earl reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-10.

Issuers

IssuerRoles in the latest filingFilingsLast filed
HRTX · HERON THERAPEUTICS, INC. /DE/CIK 818033officer (Chief Operating Officer)22026-11-10

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
HRTX · HERON THERAPEUTICS, INC. /D…Common Stock2026-11-06M exercised+31,250210,572Form 4
HRTX · HERON THERAPEUTICS, INC. /D…Common Stock2026-11-06F withheld for tax-8,889$0.29201,683Form 4
HRTX · HERON THERAPEUTICS, INC. /D…Restricted Stock Units, derivative2026-11-06M exercised-31,250$0312,500Form 4
HRTX · HERON THERAPEUTICS, INC. /D…Common Stock2026-10-30M exercised+11,770182,671Form 4
HRTX · HERON THERAPEUTICS, INC. /D…Common Stock2026-10-30F withheld for tax-3,349$0.28179,322Form 4
HRTX · HERON THERAPEUTICS, INC. /D…Restricted Stock Units, derivative2026-10-30M exercised-11,770$0153,006Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001193125-26-454742 HERON THERAPEUTICS, INC. /DE/2026-11-10
Form 4 0001193125-26-444831 HERON THERAPEUTICS, INC. /DE/2026-11-03